| scholarly article | Q13442814 |
| P50 | author | W Vallen Graham | Q73205624 |
| P2093 | author name string | Jerrold R Turner | |
| Yingmin Wang | |||
| Fengjun Wang | |||
| Brad T Schwarz | |||
| Edwina D Witkowski | |||
| P2860 | cites work | Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression | Q28347747 |
| Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis | Q28348796 | ||
| Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B | Q28379350 | ||
| IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding | Q30467607 | ||
| Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease | Q34145454 | ||
| Effect of cytokines on the epithelial function of the human colon carcinoma cell line HT29 cl 19A | Q34376559 | ||
| Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers | Q34567309 | ||
| Loosening tight junctions. Lessons from the intestine | Q34569725 | ||
| Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions | Q34786600 | ||
| T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. | Q34816745 | ||
| A porous defense: the leaky epithelial barrier in intestinal disease. | Q35651435 | ||
| Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. | Q37208648 | ||
| Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms | Q40614064 | ||
| Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms | Q40685684 | ||
| Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk | Q40735088 | ||
| Inhibition of Na+,K+-ATPase by interferon gamma down-regulates intestinal epithelial transport and barrier function | Q40811303 | ||
| Modulation of barrier function during Fas-mediated apoptosis in human intestinal epithelial cells | Q40838088 | ||
| Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta | Q40845763 | ||
| Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. | Q40880588 | ||
| Tight junctions are membrane microdomains | Q40886204 | ||
| Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin | Q40954070 | ||
| Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. | Q40990210 | ||
| Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability | Q41077484 | ||
| Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability | Q41151632 | ||
| Assessment of inflammatory events in epithelial permeability: a rapid screening method using fluorescein dextrans | Q41387016 | ||
| Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability | Q41597813 | ||
| CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability | Q41663928 | ||
| Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability | Q41738669 | ||
| Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products | Q42190722 | ||
| Tumour Necrosis factor-α induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers | Q42479137 | ||
| Long-term effects of tumor necrosis factor on LLC-PK1 transepithelial resistance | Q42503264 | ||
| Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice | Q42797638 | ||
| Transepithelial resistance can be regulated by the intestinal brush-border Na(+)/H(+) exchanger NHE3. | Q43509902 | ||
| Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy | Q43679522 | ||
| Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug | Q43756729 | ||
| Regulation of human jejunal transmucosal resistance and MLC phosphorylation by Na(+)-glucose cotransport | Q43797549 | ||
| An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin- and myosin-dependent mechanism | Q43812071 | ||
| Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: role of novel PKC isozymes | Q44265345 | ||
| TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation | Q44758263 | ||
| Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. | Q51525902 | ||
| A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. | Q53965794 | ||
| PKC-dependent regulation of transepithelial resistance: roles of MLC and MLC kinase. | Q54079243 | ||
| Activation of NF-kappaB is necessary for the restoration of the barrier function of an epithelium undergoing TNF-alpha-induced apoptosis. | Q54102357 | ||
| The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion | Q63407202 | ||
| INFLIXIMAB DOWNREGULATES INTERFERON-γ PRODUCTION IN ACTIVATED GUT T-LYMPHOCYTES FROM PATIENTS WITH CROHN'S DISEASE | Q63727345 | ||
| Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease | Q64381640 | ||
| Intestinal permeability and the prediction of relapse in Crohn's disease | Q72220492 | ||
| Antioxidant properties of aminosalicylates | Q72377087 | ||
| Effect of FR167653 on small bowel ischemia-reperfusion injury in dogs | Q73208385 | ||
| Noninvasive in vivo analysis of human small intestinal paracellular absorption: regulation by Na+-glucose cotransport | Q73533349 | ||
| Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock | Q73644807 | ||
| Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation | Q73847660 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 409-419 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression | |
| P478 | volume | 166 |
| Q40627574 | 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway |
| Q64267911 | A Role of Exopolysaccharide Produced by in the Intestinal Inflammation and Mucosal Barrier in Caco-2 Monolayer and Dextran Sulphate Sodium-Induced Experimental Murine Colitis |
| Q91473782 | A Simulated Microgravity Environment Causes a Sustained Defect in Epithelial Barrier Function |
| Q27335631 | A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease |
| Q37459893 | AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function |
| Q35183535 | Aberrant expression of the polarity complex atypical PKC and non-muscle myosin IIA in active and inactive inflammatory bowel disease. |
| Q28472412 | Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis |
| Q39292091 | Acetyl salicylic acid induces damage to intestinal epithelial cells by oxidation-related modifications of ZO-1. |
| Q30476106 | Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis |
| Q46877467 | Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells |
| Q39782336 | Adherent-invasive Escherichia coli target the epithelial barrier |
| Q34813646 | Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase |
| Q26778947 | Alcohol and the Intestine |
| Q37037647 | Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium |
| Q35895662 | Altered expression levels of occludin, claudin-1 and myosin light chain kinase in the common bile duct of pediatric patients with pancreaticobiliary maljunction |
| Q28487645 | Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway |
| Q92527296 | Anemia induces gut inflammation and injury in an animal model of preterm infants |
| Q50327258 | Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity |
| Q33780207 | Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population |
| Q37968876 | Bacteria and host interactions in the gut epithelial barrier |
| Q47110338 | Bacterial colonization stimulates a complex physiological response in the immature human intestinal epithelium. |
| Q37116525 | Bacterial particle endocytosis by epithelial cells is selective and enhanced by tumor necrosis factor receptor ligands. |
| Q37018335 | Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad |
| Q33552613 | Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice |
| Q36698786 | Beyond Ussing's chambers: contemporary thoughts on integration of transepithelial transport |
| Q43117359 | Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption via a TNF-α-regulated mechanism |
| Q38838522 | Bowel Radiation Injury: Complexity of the Pathophysiology and Promises of Cell and Tissue Engineering |
| Q34078011 | Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety |
| Q88994185 | Buckwheat and buckwheat enriched products exert an anti-inflammatory effect on the myofibroblasts of colon CCD-18Co |
| Q92668105 | Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis |
| Q41027551 | Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway |
| Q34582338 | CD137 signaling enhances tight junction resistance in intestinal epithelial cells |
| Q33788423 | Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo |
| Q39308269 | Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease |
| Q36113266 | Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. |
| Q37398298 | Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity |
| Q42492832 | Cellular zinc is required for intestinal epithelial barrier maintenance via the regulation of claudin-3 and occludin expression |
| Q38051015 | Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal? |
| Q36699701 | Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism |
| Q36026933 | Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome |
| Q92582586 | Cilostazol against 2,4,6-trinitrobenzene sulfonic acid-induced colitis: Effect on tight junction, inflammation, and apoptosis |
| Q28066092 | ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target |
| Q91971705 | Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer |
| Q36982054 | Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation |
| Q39212748 | Claudin-2 regulates colorectal inflammation via myosin light chain kinase-dependent signaling. |
| Q38809387 | Clinical importance of nonsteroidal anti-inflammatory drug enteropathy: the relevance of tumor necrosis factor as a promising target. |
| Q64102152 | Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms |
| Q54400370 | Complementary Roles of Nod2 in Hematopoietic and Nonhematopoietic Cells in Preventing Gut Barrier Dysfunction Dependent on MLCK Activity. |
| Q26861369 | Conceptual barriers to understanding physical barriers |
| Q89578153 | Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis |
| Q35052412 | Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo |
| Q36704497 | Coupling between apical and paracellular transport processes |
| Q28079482 | Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability |
| Q34555811 | Crystallization and preliminary X-ray analysis of the human long myosin light-chain kinase 1-specific domain IgCAM3. |
| Q101567971 | Culture of Intestinal Epithelial Cell Monolayers and Their Use in Multiplex Macromolecular Permeability Assays for In Vitro Analysis of Tight Junction Size Selectivity |
| Q38666232 | Curcumin protects against the intestinal ischemia-reperfusion injury: involvement of the tight junction protein ZO-1 and TNF-α related mechanism |
| Q37308566 | Cytokine regulation of tight junctions |
| Q41418721 | DT-13 Ameliorates TNF-α-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling Pathway |
| Q38834628 | Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation |
| Q89861763 | Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD |
| Q40495815 | Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state |
| Q91725417 | Dietary Chitin Particles Called Mimetic Fungi Ameliorate Colitis in Toll-Like Receptor 2/CD14- and Sex-Dependent Manners |
| Q99562875 | Dietary Supplementation with Spray-Dried Porcine Plasma Attenuates Colon Inflammation in a Genetic Mouse Model of Inflammatory Bowel Disease |
| Q39866527 | Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats |
| Q53539472 | Dietary intervention with serum-derived bovine immunoglobulins protects barrier function in a mouse model of colitis. |
| Q54346274 | Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. |
| Q42199563 | Differential partial activation phenotype and production of tumour necrosis factor-α by conventional dendritic cells in response to lipopolysaccharide in HIV+ viraemic subjects and HIV+ controllers |
| Q40186985 | Disruption of epithelial barrier by quorum-sensing N-3-(oxododecanoyl)-homoserine lactone is mediated by matrix metalloproteinases. |
| Q44001914 | Does endotoxaemia contribute to osteoarthritis in obese patients? |
| Q47806206 | Dynamic modeling of the tight junction pore pathway |
| Q43121604 | Dynamic properties of the tight junction barrier |
| Q46765488 | Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies |
| Q27324323 | Early mucosal sensing of SIV infection by paneth cells induces IL-1β production and initiates gut epithelial disruption |
| Q46304503 | Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions |
| Q43494464 | Effects of berberine on rat jejunal motility |
| Q38080687 | Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis |
| Q57279542 | Enhanced Gastrointestinal Passive Paracellular Permeability Contributes to the Obesity-associated Hyperoxaluria |
| Q50092863 | Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy |
| Q39139171 | Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens. |
| Q35836695 | Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation |
| Q53845870 | Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. |
| Q33899677 | Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function |
| Q35156930 | Epigenetic control of intestinal barrier function and inflammation in zebrafish |
| Q58580902 | Epigenetics, DNA Organization, and Inflammatory Bowel Disease |
| Q33556277 | Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation |
| Q47795925 | Epithelial Organization: The Gut and Beyond |
| Q33782512 | Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity |
| Q82215769 | Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease |
| Q34014510 | Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo |
| Q92237386 | Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κB-Mediated Activation of the MLCK-P-MLC Signaling Pathway |
| Q36741674 | Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol |
| Q38118340 | Ethanol metabolism and its effects on the intestinal epithelial barrier |
| Q88142508 | Evolving insights in the pathophysiology of complications of cirrhosis: The farnesoid X receptor (FXR) to the rescue? |
| Q34978849 | Extracellular Calcium-Sensing Receptor Inhibition of Intestinal EpithelialTNF Signaling Requires CaSR-Mediated Wnt5a/Ror2 Interaction |
| Q35649797 | Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response |
| Q37080684 | Fetal cholinergic anti-inflammatory pathway and necrotizing enterocolitis: the brain-gut connection begins in utero |
| Q37393706 | FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation |
| Q39376100 | From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases |
| Q34420883 | From intestinal permeability to dysmotility: the biobreeding rat as a model for functional gastrointestinal disorders |
| Q39877230 | GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability |
| Q34520959 | Gastrointestinal mucosal barrier function and diseases. |
| Q35847556 | Gene expression profiling in non-human primate jejunum, ileum and colon after total-body irradiation: a comparative study of segment-specific molecular and cellular responses |
| Q45743243 | Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. |
| Q37559869 | Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression |
| Q64229900 | Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability |
| Q37808740 | Gut permeability and food allergies |
| Q39102508 | Gut permeability and mucosal inflammation: bad, good or context dependent. |
| Q42207253 | HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. |
| Q30665173 | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability |
| Q36618950 | Higher expression of phosphorylated myosin regulatory light chain in the common bile duct in pancreaticobiliary maljunction accompanied by bile duct dilatation in children: a post-mortem observational study |
| Q36363577 | How stress induces intestinal hypersensitivity |
| Q39277299 | Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function |
| Q40270359 | IFN-gamma and TNF-alpha regulate human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line C2BBe1. |
| Q35215366 | IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction |
| Q37047096 | IL-1beta causes an increase in intestinal epithelial tight junction permeability |
| Q34254423 | IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway |
| Q64259788 | Identification of Serum Biomarkers for Intestinal Integrity in a Broiler Chicken Malabsorption Model |
| Q92738445 | Impaired intestinal barrier function in a mouse model of hyperuricemia |
| Q58588861 | In Vitro and In Vivo Approaches to Determine Intestinal Epithelial Cell Permeability |
| Q36522913 | In Vivo and In Vitro Antinociceptive Effect of Fagopyrum cymosum (Trev.) Meisn Extracts: A Possible Action by Recovering Intestinal Barrier Dysfunction |
| Q38902578 | Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair |
| Q42288030 | Inflammatory bowel disease therapies and gut function in a colitis mouse model. |
| Q35761217 | Inflammatory bowel disease: is it really just another break in the wall? |
| Q46592696 | Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. |
| Q36309506 | Inhibition of long myosin light-chain kinase activation alleviates intestinal damage after binge ethanol exposure and burn injury |
| Q37045757 | Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation |
| Q37578039 | Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis |
| Q37594928 | Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa |
| Q33808592 | Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways |
| Q39592093 | Interferon-γ-induced increases in intestinal epithelial macromolecular permeability requires the Src kinase Fyn. |
| Q39853564 | Interleukin-1β Mediates β-Catenin-Driven Downregulation of Claudin-3 and Barrier Dysfunction in Caco2 Cells |
| Q38417912 | Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium |
| Q89886066 | Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development |
| Q92356819 | Intestinal barrier dysfunction in severe burn injury |
| Q38584691 | Intestinal epithelial barrier function and tight junction proteins with heat and exercise |
| Q58556455 | Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis |
| Q35953647 | Intestinal macrophages arising from CCR2(+) monocytes control pathogen infection by activating innate lymphoid cells. |
| Q29618086 | Intestinal mucosal barrier function in health and disease |
| Q26859272 | Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases |
| Q92767987 | Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis |
| Q38117175 | Investigational cytokine-targeted therapies for ulcerative colitis. |
| Q39562918 | Involvement of HIF-1α in MLCK-dependent endothelial barrier dysfunction in hypoxia |
| Q37591476 | Irinotecan disrupts tight junction proteins within the gut : implications for chemotherapy-induced gut toxicity. |
| Q37914788 | Is metabolic stress a common denominator in inflammatory bowel disease? |
| Q38199343 | JAM-related proteins in mucosal homeostasis and inflammation |
| Q36854925 | JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function |
| Q37259782 | LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. |
| Q36071733 | Lipid rafts regulate PCB153-induced disruption of occludin and brain endothelial barrier function through protein phosphatase 2A and matrix metalloproteinase-2 |
| Q28568715 | Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism |
| Q33816018 | Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier |
| Q47413203 | Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis |
| Q47313771 | MARCKS-related protein regulates cytoskeletal organization at cell-cell and cell-substrate contacts in epithelial cells. |
| Q38301696 | MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro |
| Q24317362 | Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability |
| Q37047106 | Mechanism of cytokine modulation of epithelial tight junction barrier |
| Q37047083 | Mechanism of glucocorticoid regulation of the intestinal tight junction barrier |
| Q37629444 | Mechanisms and functional implications of intestinal barrier defects |
| Q37594944 | Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli. |
| Q26774688 | Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection |
| Q38099727 | Mechanisms of action of anti-tumor necrosis factor α agents in Crohn's disease |
| Q34464682 | Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases |
| Q58774497 | Mechanisms regulating intestinal barrier integrity and its pathological implications |
| Q64103290 | Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation |
| Q28077783 | Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer |
| Q28555167 | Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice |
| Q41483056 | Modulation by thyroid hormone of myosin light chain phosphorylation and aquaporin 5 protein expression in intact lung. |
| Q36421582 | Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen |
| Q34789106 | Modulation of lipopolysaccharide-induced neuronal response by activation of the enteric nervous system |
| Q52609696 | Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases. |
| Q35984123 | Molecular and cellular mechanisms of food allergy and food tolerance. |
| Q26864785 | Molecular aspects of tight junction barrier function |
| Q35569905 | Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application |
| Q38953543 | Molecular pathways driving disease-specific alterations of intestinal epithelial cells |
| Q36439020 | Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants |
| Q38293774 | Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease |
| Q38810529 | Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. |
| Q34110996 | Multiple facets of intestinal permeability and epithelial handling of dietary antigens |
| Q41982611 | Murine guanylate cyclase C regulates colonic injury and inflammation |
| Q52647636 | Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions. |
| Q35092790 | Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis |
| Q46830240 | Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. |
| Q43474062 | Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice |
| Q35085249 | Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. |
| Q31057409 | Myosin light chain kinase mediates intestinal barrier disruption following burn injury |
| Q38739653 | Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury. |
| Q36062835 | Myosin light chain kinase: pulling the strings of epithelial tight junction function |
| Q80809479 | NF-kappaB p50 and p65 subunits control intestinal homeostasis |
| Q38683067 | Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease |
| Q35664929 | Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses |
| Q42082089 | No static at all. |
| Q90168292 | Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis |
| Q99593443 | Non-lethal Plasmodium yoelii infection drives complex patterns of Th2-type host immunity and mast cell-dependent bacteremia |
| Q42811392 | Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration |
| Q37197950 | Novel mechanism of cytokine-induced disruption of epithelial barriers: Janus kinase and protein kinase D-dependent downregulation of junction protein expression |
| Q47221249 | Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development |
| Q30009590 | Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux |
| Q34918139 | Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function |
| Q36323908 | Olive oil bioactives protect pigs against experimentally-induced chronic inflammation independently of alterations in gut microbiota |
| Q26738728 | Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues |
| Q51614351 | Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. |
| Q55245208 | Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. |
| Q64058580 | Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier |
| Q85948686 | Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation |
| Q28507355 | Overexpression of Ste20-related proline/alanine-rich kinase exacerbates experimental colitis in mice |
| Q35235187 | Oxymatrine improves intestinal epithelial barrier function involving NF-κB-mediated signaling pathway in CCl4-induced cirrhotic rats |
| Q42471534 | Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2. |
| Q35689533 | Pathogenic potential of Campylobacter ureolyticus |
| Q36943034 | Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall |
| Q36996000 | Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women |
| Q38211365 | Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation |
| Q39578562 | Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation |
| Q89685652 | Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of SIV-infected Rhesus Macaques |
| Q33309955 | Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity |
| Q30425823 | Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism |
| Q37387991 | Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression |
| Q34166824 | Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins |
| Q46889906 | Proinflammatory effect of trivalent arsenical species in a co-culture of Caco-2 cells and peripheral blood mononuclear cells |
| Q42877924 | Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD. |
| Q37994635 | Proteases and the gut barrier. |
| Q37396622 | Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications |
| Q38265533 | Protein kinases are potential targets to treat inflammatory bowel disease |
| Q41378914 | Pseudomonas fluorescens alters the intestinal barrier function by modulating IL-1β expression through hematopoietic NOD2 signaling. |
| Q28078842 | Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals |
| Q50922715 | Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber. |
| Q39336319 | Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2. |
| Q34287155 | Regulation of intestinal epithelial permeability by tight junctions. |
| Q33491056 | Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines |
| Q28246127 | Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues |
| Q38141920 | Regulation of paracellular permeability: factors and mechanisms. |
| Q90705632 | Regulation of the intestinal barrier by nutrients: The role of tight junctions |
| Q36291601 | Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction. |
| Q33559181 | Role of myosin light chain kinase in intestinal epithelial barrier defects in a rat model of bowel obstruction |
| Q37026888 | Role of non-muscle myosin light chain kinase in neutrophil-mediated intestinal barrier dysfunction during thermal injury |
| Q37058869 | Role of the intestinal barrier in inflammatory bowel disease |
| Q37028447 | Secreted Listeria adhesion protein (Lap) influences Lap-mediated Listeria monocytogenes paracellular translocation through epithelial barrier |
| Q36483860 | Segmental Differences in Radiation-Induced Alterations of Tight Junction-Related Proteins in Non-Human Primate Jejunum, Ileum and Colon |
| Q55517489 | Severe Burn-Induced Intestinal Epithelial Barrier Dysfunction Is Associated With Endoplasmic Reticulum Stress and Autophagy in Mice. |
| Q41588684 | Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: Inhibition by berberine |
| Q38696638 | Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function. |
| Q37289295 | Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function. |
| Q36642527 | Stimulus-induced reorganization of tight junction structure: the role of membrane traffic |
| Q38180279 | Stromal regulation of embryonic and postnatal mammary epithelial development and differentiation |
| Q38718585 | TGF-β1 protects intestinal integrity and influences Smads and MAPK signal pathways in IPEC-J2 after TNF-α challenge |
| Q35043980 | TGFβs modulate permeability of the blood-epididymis barrier in an in vitro model |
| Q27015742 | TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity? |
| Q37636048 | The Effect of Oral Intake of Low-Temperature-Processed Whey Protein Concentrate on Colitis and Gene Expression Profiles in Mice. |
| Q39406091 | The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration. |
| Q33842314 | The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer |
| Q91722641 | The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation |
| Q40216858 | The innate immune responses of colonic epithelial cells to Trichuris muris are similar in mouse strains that develop a type 1 or type 2 adaptive immune response |
| Q39398254 | The intestinal barrier: a fundamental role in health and disease |
| Q39009998 | The intestinal epithelial barrier: a therapeutic target? |
| Q36310293 | The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease |
| Q91241929 | The many faces of tumor necrosis factor signaling in the intestinal epithelium |
| Q90499640 | The mechanobiology of tight junctions |
| Q57291610 | The microbiome and HLA-B27-associated acute anterior uveitis |
| Q34617424 | The role of molecular remodeling in differential regulation of tight junction permeability |
| Q33505862 | The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failure |
| Q38753779 | The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction |
| Q28289667 | The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease |
| Q41545568 | The squid ink polysaccharides protect tight junctions and adherens junctions from chemotherapeutic injury in the small intestinal epithelium of mice |
| Q37457219 | The tight junction in inflammatory disease: communication breakdown |
| Q36305755 | Tight Junction Pore and Leak Pathways: A Dynamic Duo |
| Q40864710 | Tight Junction Ultrastructure Alterations in a Mouse Model of Enteral Nutrient Deprivation. |
| Q38189138 | Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? |
| Q36950607 | Tight junctions on the move: molecular mechanisms for epithelial barrier regulation |
| Q89744172 | Total Flavonoid Extract from Hawthorn (Crataegus pinnatifida) Improves Inflammatory Cytokines-Evoked Epithelial Barrier Deficit |
| Q90296333 | Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer via the nuclear factor-κB-myosin light chain kinase-myosin light chain pathway |
| Q54401840 | Transplantation of human umbilical mesenchymal stem cells attenuates dextran sulfate sodium-induced colitis in mice. |
| Q38671207 | Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. |
| Q50554366 | Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells. |
| Q36285773 | Tumor necrosis factor alpha increases intestinal permeability in mice with fulminant hepatic failure |
| Q50920142 | Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. |
| Q53835631 | Wild jujube polysaccharides protect against experimental inflammatory bowel disease by enabling enhanced intestinal barrier function. |
| Q41415165 | Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling. |
| Q48350421 | Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions |
| Q30157199 | ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton |
Search more.